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Abstract
Background: Various tick-borne infections often occur without specific clinical signs and are therefore notoriously
hard to diagnose separately in veterinary practice. Longitudinal studies over multiple tick seasons performing
clinical, serological and molecular investigations in parallel, may elucidate the relationship between infection and
disease. In this regard, six related Rhodesian Ridgeback dogs living as a pack became subject of lifetime studies due
to ongoing tick infestations and recurring clinical problems. Blood samples for diagnostic tests were obtained
throughout the years 2000 to 2009.
Methods: Data collected from clinical observations, hemograms, serology and detection of Anaplasma
phagocytophilum, either by microscopy or by DNA amplification and typing, were placed in a time line.
This dataset essentially presents as a prospective study enabling the association of the Anaplasma infections
with occurring disease.
Results: All six dogs were infected, and two of them developed particular clinical symptoms that could be
associated with Anaplasma infections over time. More specifically, episodes of general malaise with fever and
purpura with thrombocytopenia and bacterial inclusions in granulocytes, were found concurrently with
Anaplasma DNA and specific antibodies in peripheral blood samples. DNA from A. phagocytophilum variant 4
(of 16S rRNA) was found in multiple and sequential samples. DNA-sequences from variant 1 and the human
granulocytic ehrlichiosis (HGE) agent were also detected.
Conclusions: In this study two lifelong cases of canine anaplasmosis (CGA) are presented. The data show
that dogs can be naturally infected concurrently with A. phagocytophilum variant 1, variant 4 and the HGE
agent. The ongoing presence of specific antibodies and Anaplasma DNA in one dog indicates one year of
persisting infection. Treatment with doxycycline during recurring clinical episodes in the other dog resulted in
transient clinical improvement and subsequent disappearance of specific antibodies and DNA suggesting that
re-infection occurred.
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Background
Anaplasma phagocytophilum one of the pathogens
found in Ixodes ricinus, is capable of infecting a broad
range of animal species [1, 2]. After introduction into
the skin with tick saliva, the bacterium is incorporated
in the vacuole of a neutrophilic granulocyte, where
multiplication results in a microscopically visible morula
and dysregulation of bactericidal neutrophilic functions
[3]. Clinical signs have been described in sheep, cattle,
horses, dogs and humans [2, 4, 5]. After taxonomic
revision, the (sub)species infecting these animals were
clustered in one species designated A. phagocytophilum
but remain classed as variants [6]. These variants are
identified on the basis of sequence differences in the 16S
rRNA or other genes and in dogs they appear to deter-
mine the clinical outcome [7–9]. Domesticated animals
and man share their ecotype variants with red deer,
swine and hedgehogs [10]. The European hedgehog
(Erinaceus europaeus) can be regarded as one of the most
important wildlife reservoirs for A. phagocytophilum
maintaining the infection cycle to humans and ca-
nines [11–13].
Tick-borne infections in the dog, when symptomatic,
do not result in a differentiable clinical picture [14]. No
single symptom can be appointed as pathognomonic for
an A. phagocytophilum infection, but fever with severe
pain and thrombocytopenia warrants serological and
molecular testing for Anaplasma. Other possible signs
include pale mucous membranes with petechiae, scleral
bleeding, tachypnoea, enlarged lymph nodes, gastro-
intestinal signs (tense abdomen/splenomegaly) and
lameness and notably a reluctance to move [15, 16]. An
active Anaplasma-infection can be diagnosed by micro-
scopic detection of morulae in granulocytic white blood
cells or by demonstrating emerging specific antibodies
(seroconversion) [17]. Fever intensity and severity of
thrombocytopenia relates to the number of infected
neutrophils. Detection of Anaplasma DNA in peripheral
blood is more sensitive presenting before and after
morulae. Persistence of infection during two months or
more is generally encountered in experimentally infected,
deliberately immunosuppressed, dogs [14, 18–20]. How-
ever, persistence of infection in household dogs is debated
and has not yet been determined unequivocally [15, 21].
Lifelong investigations of six frequent tick infested
Rhodesian Ridgeback dogs comprising a 9-year period of
parallel observations, on clinical signs and laboratory
assays, reveals symptomatic anaplasmosis in two dogs.
Methods
Dogs and diagnostic sampling
Six female Rhodesian ridgeback dogs living in one
household were under care of a local veterinarian
(KEH). The dogs home was situated at the village border
(Veldhoven, Kempen area, province of Brabant, the
Netherlands) with a large semi-natural garden including
natural woodland. The dogs roamed loose and were
daily walked in surrounding woodlands. Dog M12 (born
1994) was mother of dogs L11, L12, L13 (born 1998)
and L21 (born 1999); both litters from one sire (Fig. 1).
Dog N00 was distantly related and one year older than
M12. Dogs were presented for consultation whenever
health problems were suspected, and results of the clin-
ical examinations were filed. Routine vaccinations were
only administered in the first years. Tick repellents or
acaricidal topicals with high efficacy were not available
at the time of study, and thus were not applied. When
diagnostically necessary venous blood samples were
taken and examined in view of the clinical presentation.
Ultimately, when severely ill and elder, the dogs were eu-
thanized on the owner request, however one dog died
naturally. With the owners’ informed consent, tissues for
histopathology were subsequently obtained from all dogs
except N00 and examined by a certified veterinary path-
ologist. In addition, a sample of spleen tissue was frozen
for later use. Venous blood was sent to a reference la-
boratory for automated red and white blood cell counts.
Blood smears were microscopically viewed in house for
cell forms and inclusion bodies and in later years, cell
differentiations and counts were also done in house.
Blood chemical analysis was performed on all samples
with an in house automatic analyzer (Spotchem, Menarini,
Valkenswaard, the Netherlands). Routinely, urea, creatin-
ine, glucose, total protein, albumin, alkaline phosphatase,
glutamate transaminase and total calcium were tested.
Serological methods
Anaplasma-specific serology was performed at different
laboratories and with in-house test kits. Immunofluorescent
Fig. 1 The pack, six female Rhodesian ridgeback dogs in the large
garden adjacent to oak-pinewood forests
Hovius et al. Parasites & Vectors  (2018) 11:238 Page 2 of 12
antibody tests for at the time named Ehrlichia phago-
cytophila and Ehrlichia canis were performed on the
2001 samples. An immunoblot with the p44 protein
of A. phagocytophilum, was performed on the 2001
through 2003 samples. Later in 2009, the SNAP®
4Dx-test (IDEXX Laboratories, Westbrook, ME, USA)
that also detects antibodies against the p44 protein
became available and all sera were retrospectively
tested in house. This in-house test also detects anti-
bodies against E. canis, the C6 antigen of Borrelia
burgdorferi (sensu lato) and heartworm antigens.
Moreover, a whole cell Elisa for the detection of B.
burgdorferi (s.l.) antibodies was used on selected sera.
Molecular agent detection
For detection of Anaplasma DNA, blood samples were
distributed over several laboratories using different tar-
gets. DNA extraction was performed as described for
Anaplasma studies in Swedish dogs [22]. Importantly,
16S rRNA gene-based PCR assay was performed in
which the DNA products were subjected to a reversed
line blot (RLB) detecting the different variants of A.
phagocytophilum [23, 24]. Briefly, oligonucleotide probes
characterizing the A. phagocytophilum variants were
covalently coupled in a linear manner to slots of a
miniblotter (Immunetics, Cambridge, Mass, USA). The
biotin labeled denatured PCR product was applied into
the slots to hybridize with the probes. Hybridization was
confirmed by visualizing the chemiluminescence reac-
tion after coupling of biotin and streptavidin-peroxidase.
Probes employed were specific for A. phagocytophilum
variants 1 and 2 mostly found in cattle and sheep, and
variants 3 and 4 found in ticks and dogs, for the variant
most found in horses Ehrlichia equi named “E. equi”,
and for the variant first detected in a human patient;
“human granulocytic ehrlichiosis”, abbreviated as “HGE
agent” (now the agent of human granulocytic anaplas-
mosis, HGA agent). GenBank accession numbers of
these variants are: A. phagocytophilum variant 1,
M73220, formerly Ehrlichia phagocytophila Old Sour-
hope, from sheep from Scotland [25]; A. phagocytophi-
lum variant 2, AF336220, formerly new variant from
sheep Norway [24]; A. phagocytophilum variant 3,
AJ242784, formerly Swedish Tick Ehrlichia type IIb [26];
A. phagocytophilum variant 4, AJ242783, formerly
Swedish Tick Ehrlichia type Ib and Rosa dog isolate [22];
E. equi, AF036646; HGE agent, U02521, Human
Granulocytic Ehrlichia, from man Wisconsin USA, [27].
In 2014, frozen spleen samples of 5 of the 6 dogs and
selected known positive full blood samples of dog M12
and L11, were tested by PCR. DNA was extracted using
the Qiagen DNeasy® Blood & Tissue Kit (Qiagen, Venlo,
the Netherlands) according to the manufacturer’s proto-
col for the purification of total DNA from blood and
tissues. Detection of A. phagocytophilum and “Candida-
tus Neoehrlichia mikurensis” DNA by qPCR, was per-
formed as described earlier [9, 28]. Briefly, for detection
of DNA of both pathogens, a single multiplex qPCR
assay was used, which targets specific regions of gene
msp2 (p44, Major Surface Protein 2) for A. phagocyto-
philum, and groEL (heat shock protein) for “Candidatus
N. mikurensis”. Confirmation was obtained by conven-
tional PCR using EphplgroEL-A.phago-F (5'-ATG GTA
TGC AGT TTG ATC GC-3') and EphgroEL-A.phago-R
(5'-TTG AGT ACA GCA ACA CCA CCG GAA-3') as
primers with the following cycling program: 15 min at
95 °C, 40 cycles each consisting of 30 s at 94 °C, 57 °C
and 72 °C, and final extension for 10 min at 72 °C.
Results
Results of the molecular and serological tests are shown
in Table 1. Anaplasma phagocytophilum DNA was
detected in blood samples from two dogs; dog M12 and
dog L11 (a daughter from the first litter of M12) with
uniform results for all methods. In dog L11, A. phagocy-
tophilum DNA was also detected in spleen tissue.
Because the dogs were presented mainly whenever
health problems occurred, the frequency and time of
their tests was irregular (Additional file 1: Table S1). All
six dogs were found serologically positive at least once
in their lifetime.
Dog M12 was presented with a first episode of fever
(40.0 °C) after her third litter; was painful and had
atrophy of the right temporal muscle. The abdomen was
bulgy and tense with a grossly enlarged spleen. Endo-
metritis and enteritis was suspected and after ovariohys-
terectomy (OVH) and treatment with amoxicillin (10 mg
bid for 3 days and one injection dexamethasone (10 mg)
the dog recovered except for the atrophic right temporal
muscle. A few months later she was put on non-steroid
anti-inflammatory drugs (Metacam®, NSAID, Boehringer
Ingelheim Vetmedica, Inc.) because of reluctance in
lying down and getting up and the development of a “fer
de lance” (an atrophied muscle segment) of the left loin
muscle. The dog recovered completely, with the
temporal muscle regaining normal proportions. How-
ever, although apparently healthy, she still had antibodies
against A. phagocytophilum and Anaplasma DNA (A.
phagocytophilum variant 4) in her blood. The blood
smear and cell counts were abnormal and granulocytic
morulae were observed (Additional file 1: Table S1).
Later, she was presented with a second fever episode
(39.9–40.4 °C) with thrombocytopenia, anemia and in-
testinal bleeding (melena) apparently commencing with
swelling of the left mandibular lymph node. Fever and
melena resided after doxycycline (Ronaxan®, Merial,
Lyon, France) therapy, but as the dog developed exten-
sive subcutaneous exudate and appeared severely painful
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she was euthanized on the owners’ request. Blood
chemistry for liver and kidney function had always been
within the normal range. In all dogs, blood chemistry
values were determined in parallel with all cell counts
and all results were within the normal range (data not
shown). No tumors were detected on complete gross
pathology of dog M12 nor seen histologically in liver or
spleen. The liver was congested and spleen infarctions
were noted.
Dog L11 and its littermates (L12, L13) had juvenile
pyoderma when a few weeks old. This dog was provi-
sionally diagnosed with four clinical episodes of canine
granulocytic anaplasmosis (CGA) (see Additional file 1:
Table S1). In the first episode, doxycycline (Ronaxan®)
therapy 5 mg per kilo bid for 10 days, was prescribed, in
the later prescriptions the dose was 10 mg per kilo bid.
During the first episode of disease, at the age of 3 years,
dog L11 was presented with ecchymosis over the ventral
abdominal skin (Fig. 2), and bleedings under the tongue,
buccal mucosa as well on the inside of the ear. The
purpura resided within 5 days (Fig. 3). No fever was
noted. Thrombocytes were low (9 cells/nl) but recovered
slightly within a week and remained at subnormal levels
during the following 4 months. Neutrophilia was
followed by lymphocytosis (Tables 2 and 3). DNA of A.
phagocytophilum variants 1 and 4 was detected in blood.
Doxycycline therapy was installed and 3 weeks later
Anaplasma DNA was no longer detected; this therapy
was repeated 3 more times. About 15 months later the
dog developed a second episode of fever (39.6 °C) with
thrombocytopenia (50 cells/nl) and morulae in neutro-
phils. Again, DNA of A. phagocytophilum variants 1 and
4 was found in blood samples and this time also the
HGE agent was detected as well. Doxycycline therapy
was again initiated. When tested three weeks later no
Anaplasma DNA was detected. Antibodies disappeared
from the circulation within 2 months. A third and fourth
episode including fever thrombocytopenia and purpura
with circulating antibodies occurred in 2005 and 2008.
During the last episode, a slow growing lung tumor was
detected. Fifteen months later the dog was euthanized.
Her spleen tissue contained A. phagocytophilum DNA
and histology revealed a severe splenitis with follicular
hyperplasia and as in lung tissues contained undefinable
tumor like cells. The other four dogs were also infected
but no symptoms indicating possible CGA were ob-
served (Additional file 1: Table S1). One of these dogs,
L12, was spayed (ovariohysterectomy) when she had a
high fever (39.8 °C), supposedly caused by an endometri-
tis. The laparoscopy showed a slightly enlarged uterus
and a grossly enlarged spleen, histologically diagnosed as
a splenitis which was negative for Anaplasma DNA.
Morulae were observed in neutrophils, but blood sam-
ples were negative for Anaplasma DNA. At the moment
SNAP® 4Dx test was positive for p44 antibodies. Dogs
L13, L21 and N00 developed haemangiosarcoma, lymph-
oma and melanoma, respectively and mammary tumors
as well. No morulae were observed, nor was DNA de-
tected in peripheral blood or in the spleen. Anti-p44
antibodies were detected in all three dogs at least once
during the live time. The SNAP® 4Dx test never detected
specific antibodies against other tick-borne infections
during this study (for dog L11 see Tables 2 and 3).
Discussion
This longitudinal study, in essence a prospective
study, shows that each member of a pack of six
Rhodesian ridgeback dogs was infected at least once
in its life with the tick-borne bacterium A. phagocyto-
philum (Additional file 1: Table S1). During the tick
season, the dogs were almost daily infested with multiple
ticks (see Tables 2 and 3 for dog L11) of which, in a previ-
ous study (2006–2009), at least 2.5% appeared to harbour
Fig. 2 Dog L11 at first presentation in the veterinary clinic, with
acute ecchymosis
Fig. 3 Dog L11 with the purpura residing within 5 days
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Table 2 Clinical episodes of dog L11 in 2001 and 2002 as determined by symptoms, hematology, serology and pathogen detection
by PCR or microscopy. Four clinical episodes were detected in the years 2001, 2002, 2005 and 2008. Symptoms were not always
accompanied by fever and bleeding tendency was not always apparent. Other symptoms as lymphadenopathy, muscle pain,
lameness, reluctance to move and lethargy were also observed
Year 2001 2002
Day/Month 23/04 27/04 14/05 29/06 28/08 09/02 07/03 21/06 03/09 23/09 25/09 18/10
Hematology (reference)
Erythrocytes (> 5.5/pl) 7.05 6.21 6.78 7.84 7.56 7.11 6.75 7.15 5.72 6.33 6.46
Hemoglobin (> 8.8 mmol/l) 10.66 9.42 10.23 11.90 10.97 10.60 10.66 11.04 8.37 9.05 9.61
HT (> 42%) 51 46 48 61 56 54 49 52 39 43 50
MCV (65.5–75.5 fl) 71.70 73.60 71.10 77.30 73.90 75.40 73.20 72.50 67.80 68.20 78.10
MCH (0.90–1.55 pmol) 1.46 1.47 1.46 1.47 1.40 1.45 1.53 1.49 1.42 1.39 1.45
MCHC (20.9–22.3 mmol/l) 21.08 20.58 21.2 19.59 19.59 19.78 21.58 21.20 21.64 21.02 19.10
Thrombocytes (150–400/nl) 9 50 131 23 17 192 216 180 50 187 206
Leukocytes (5.9–13.8/nl) 11.4 11.6 14.5 8.4 8.9 7.9 7.9 8.2 7.8 6.8 8.5
Neutrophils (55–75%) 73 79 71 55 67 65 66 61 78 42 73
Lymphocytes (13–30%) 16 18 16 35 22 27 23 33 9 52 21
Monocytes (< 5%) 8 1 4 9 5 6 2 5 9 4 5
Eosinophils (< 4%) 2 1 6 1 4 1 9 1 0 2 1
Basophils (< 1%) 0 0 0 0 0 0 0 0 0 0
Staphylococcus (< 4%) 1 1 3 0 2 1 0 0 4 0 0
Serology
Anaplasma Immunoblot neg2 neg2 neg2 neg3 neg3 neg3 neg3 neg3 pos3 pos3 pos3
IFT pos1 pos1 neg1
Snap test neg neg neg neg neg neg pos neg
Borrelia WHC-titer 80 40
C6 Snap test neg neg neg neg neg neg neg neg neg
Coagulation test normal
Microscopy (morulae) pos neg neg neg neg neg neg pos neg neg
PCR - DNA pos2,4 neg2 pos2 neg2 neg3 neg3 neg3 neg3,4 pos1,3,4 pos3 neg1,3
RLB A. phago variant 1 pos2 neg pos3 neg
A. phago variant 2 neg neg neg neg
A. phago variant 3 neg neg neg neg
A. phago variant 4 neg pos2 pos3 neg
E. equi neg neg
HGE agent neg neg pos3 pos3
Clinics
Body temperature 38.8 38.4 38.4 38.5 38.2 38.3 38.3 38.2 39.6 38.5
Bleeding ecchm resolv no no no no no no no no no no
Other listless, lymphaden. R
popliteus
pseudolac lame myositis, lays, pseudolac,
lameness
pseudolac dyspneu cough
Therapy doxy doxy doxy doxy doxy amox/clv
Ticks on dog yes yes yes yes yes yes
Notes: Deviant or positive laboratory results are shown in bold. Serology and Anaplasma DNA detection employed different methods which were
performed in different years and laboratories indicated by numbers 1 to 4. Assay method depended on laboratory and year of processing and is
indicated as:1VMDC till 2008; 2RIVM in 2001; 3RIVM in 2003; and 4RIVM in 2014. The in-house SNAP® 4Dx test (IDEXX) was employed to determine
antibodies against the p44 antigen, which was also detected by immunoblot in the first 2 years as was the IFA (immunofluorescent assay) in the
first year. The agent detection by 16S rRNA gene amplification and confirmed by reverse line blot hybridization (RLB) detecting variants of
A. phagocytophilum was performed in the first two years. Time of doxycycline therapy and of tick collections from skin are notated
Abbreviations: pos positive, neg negative, pseudolac pseudo-lactation after estrous, OVH spaying by ovariohysterectomym lymphaden lymphadenopathy,
ecchm ecchymosis, resolv resolving, A. phago A. phagocytophilum, E. equi Ehrlichia equi, doxy doxycyclin,
amox/clv amoxicillin with clavulanic acid
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A. phagocytophilum [29]. Canine granulocytic anaplasmo-
sis (CGA) had not been diagnosed in the region before,
however, establishing this diagnosis greatly depends
on the timing of diagnostic sampling and its fre-
quency. Experimental and clinical studies show that
periods in which morulae and/or specific DNA are
detectable in blood are relatively short; testing one
sample may not be enough to exclude infection.
Therefore, sequential sampling, as with dog L11, con-
siderably increases the chance of detecting the agents,
presence or short-lived antibodies [30]. Moreover, A.
phagocytophilum infections vary in their clinical
expression and the induced pathology is far less pro-
nounced than that of other ehrlichiae [14].
Two of the six dogs in the pack (dog M12 and dog
L11) showed symptoms as fever, bleeding tendencies,
general painfulness (resulting in a reluctance to move)
combined with thrombocytopenia and neutrophilia
followed by lymphocytosis. These observations are simi-
lar to the first clinical and experimental case reports of
A. phagocytophilum infections from Sweden [16, 17, 20]
and are in line with the observations from clinical stud-
ies from other countries [3, 15, 31, 32]. Diagnosing CGA
should be based on the synchronous occurrence of: (i)
attributable symptoms, with (ii) abnormal findings in the
blood smear including thrombocytopenia, and (iii) de-
tection of active infection by molecular assays or micro-
scopic observation of granulocytic morulae combined
with specific antibody detection [15]. During its lifetime
dog L11 showed these three criteria were synchronously
at 4-time points (out of 17-time points that tested the
three classes of observations simultaneously). This case
can, therefore, be considered as an established case of
CGA (Tables 2 and 3).
The in-house test measuring the specific p44 anti-
bodies has a high sensitivity [33]. The msp2/p44 gene
consists of a large potential of pseudogenes enabling dir-
ect insertion into the expression site, inducing variability
of the epitopes [34]. In a canine model, antibodies
against the p44 antigen were shown to occur only for a
short time after infection or to persist during continued
subclinical or chronic infection [14, 18]. In naturally in-
fected lambs, successive febrile peaks occur, and the p44
antibodies against the recombined epitopes appear with
each remission whereas Anaplasma bacteria remain de-
tectable for one day only [24, 30]. A close observation
on the sequential measurements of dog L11 clarifies that
as in lambs the antibody reaction against p44 was
only measured for a short time period. Measuring
anti-p44 antibodies thus appears as sensitive as agent
detection and might indicate active and not past in-
fection (Tables 2 and 3).
Dog M12 had two fever episodes within a year and
was also sampled in between the two episodes. Initially,
IFA antibodies were demonstrated during the first epi-
sode. Later, when samples taken between the two
episodes, when the dog appeared clinically healthy, p44
antibodies, morulae and Anaplasma DNA were found
(Additional file 1: Table S1). The dog was at first treated
with a corticosteroid and a NSAID, because of supposed
myositis, and with amoxicillin. During the second
fever episode, when Anaplasma DNA was again de-
tected, treatment with doxycycline was started. In
retrospect, the aspects of this second fever episode,
including bleeding tendencies (melena) together with
thrombocytopenia, warranted the diagnosis CGA.
However, the aberrant spleen, that was excised after
euthanasia, at three weeks after the last positive blood
sample, did not contain Anaplasma DNA, supposedly
because of the doxycycline administered (3 weeks be-
fore). It is unclear whether the circulating Anaplasma
bacteria detected in-between the two symptomatic
periods were due to persistence of the agent or to
reinfection. Persistence is a possible option as doxy-
cycline had not yet been administered. However, re-
infection is also possible since the ‘tick season’ had
just begun. Notably, agent persistence has not been
unequivocally demonstrated outside experimental set-
tings [19, 21, 30].
Dog L12 was clearly infected with A. phagocytophilum
in 2003, when morulae and antibodies were present. How-
ever, in 2004, when the dog fell ill showing symptoms such
as fever, pain, an enlarged spleen and antibodies, these
symptoms cannot be unequivocally attributed to the
Anaplasma infection. Dogs L13, L21 and N00 showed
symptoms indicating immunosuppression (tumor, worm
infections, eosinophilia) at the time they tested positive for
A. phagocytophilum antibodies but no CGA appropriate
clinical signs nor thrombocytopenia were observed.
Exclusion of a causative role of other tick-borne
agents for the observed symptoms was obtained by
the SNAP® 4Dx test that did not reveal any sample
positive for antibody responses to B. burgdorferi (s.l.)
or E. canis. The latter, could, in the acute phase, also
elicit bleeding and thrombocytopenia, and would
present with morulae in monocytes, which were not
detected. Moreover, the IFA for E. canis, employed in
episode I of dog L11 was negative (data not shown).
There were no inclusion bodies in thrombocytes that
would indicate an Anaplasma platys infection and
this bacterium has not been detected in Dutch ticks.
Autochthonous canine babesiosis is excluded by spe-
cific PCR on the samples tested at the VMDC. More-
over, no piroplasms were observed in erythrocytes.
The qPCR performed in 2014 was also able to detect
DNA of “Candidatus N. mikurensis” but did not yield
an amplification product for this target in the samples
from this study. This novel agent was detected in 5%
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of questing ticks of the studied Kempen region and
may cause symptoms similar to granulocytic
anaplasmosis in dogs [28, 35, 36]. Low Borrelia whole
cell values and absence of anti-Borrelia C6 antibodies
in all six Ridgebacks is noteworthy. In the regional
population of tick infested dogs, Borrelia infection
rates of 100% have been found and canine Lyme bor-
reliosis may be diagnosed [37–39].
Analysis of the Anaplasma PCR products using the re-
versed line blot (RLB) yielded three A. phagocytophilum
variants. Anaplasma phagocytophilum variant 1 and
variant 4 were found in episode I and II of dog L11. Re-
markably, in the same quarter year, A. phagocytophilum
variant 4 was also found in dog M12 (Additional file 1:
Table S1). The third variant, “HGE agent” (HGA agent),
was found during episode II of dog L11. The episode I
infection is supposedly cleared by the doxycycline re-
peatedly applied, as A. phagocytophilum is very sensitive
to this antibiotic [40]. Since antibodies were not detect-
able between episode I and II, reinfection (with the
different variants not necessarily at the same time)
would be the most parsimonious explanation. Re-
infections have been demonstrated for naturally infected
horses and humans, but so far not in naturally or experi-
mentally infected dogs [15, 18, 21]. Persistence, on the
other hand, with declining p44 antibody reactions has
been described for naturally and experimentally infected
lambs and experimentally infected dogs [20, 30, 41]. The
dog could have remained infected with one or both of
the two A. phagocytophilum variants, i.e. 1 and 4. A
hesitantly recovering thrombocytopenia, as between epi-
sodes I and II, has been suggested to be an indication of
non-circulating inactive bacteria at sub-detection levels
[18]. Further, detailed characterization of the infecting
strains in episodes I and II may reveal if persistence or
reinfection has occurred.
The simultaneous detection of variants in one and
the same sample of lambs is not a rule but rather an
exception, indicating that “it may be difficult to ob-
tain all variants involved in naturally infected animals”
as stated by Stuen and colleagues [41]. Thus, accord-
ing to Stuen et al. [41], although present the variants
do not circulate together, implying that the results of
samples different variants two days apart may never-
theless be interpreted as co-occurring. Thus, in dog
L11 co-infection of two and three variants might have
occurred in episodes I and II, respectively.
The pathogenic role of A. phagocytophilum variant
1 in the canine is uncertain; in the present study this
classic sheep variant is reported in dogs for the first
time. This variant may be an innocent bystander or
alternatively divert the immune system, enabling the
other variants to thrive. Previous studies show that
the “HGE agent” (HGA agent) appears to be more
pathogenic for dogs than other variants [7]. In
addition, in nearly all case reports of CGA the causative
agent is thought to be the “HGE agent” (HGA agent)
based on 16S rRNA identities [7, 22, 26, 42–45], as we also
observed in episode II of dog L11. Anaplasma phago-
cytophilum variant 4, which has sometimes been indi-
cated as a “HGE variant” [22, 26], was detected in
two episodes of dogs L11 and M12 and probably
contributes to pathogenesis.
The higher prevalence rates for engorging (19.5%)
than for questing ticks (2.5%) suggests that dogs play
a role in delivering A. phagocytophilum to ticks, i.e.
dogs are likely to have a reservoir function at a local
scale [36, 46]. This canine reservoir function was
demonstrated experimentally and suggested to have
an enzootic function in public parks in Germany
[18, 47–49]. In analogy with this, it might be that
heavily tick infested dogs M12 and L11 established
an enzootic cycle in their large garden by importing
infected ticks from the woods where they were
walked, thereby increasing the chance of enhancing
a virulent canine clone. This hypothetical dynamic
transmission by ticks between the dogs in this pack
would have increased the chance of infection and re-
infection analogous as in a flock of lambs [50].
The “Kempen” region where these dogs were living,
is a known high-risk area for A. phagocytophilum in-
fections [46, 51]. In humans, only a few cases have
been described in this area [52, 53] but until now no
associated clinical disease had been reported in dogs.
By the longitudinal study of a pack of six Rhodesian
ridgeback dogs we showed that A. phagocytophilum
variant 4 infection was associated with typical disease
in two of these dogs. Our results further indicate
that re-infection and putatively persistence of
Anaplasma infection occurs in naturally infected
dogs. Confirmation may be obtained by detailed
analysis, comparing the variable msp2/p44 gene of
amplified variants in the time line [54]. Comparing
these variants to those causing known clinical cases
in other regions is needed to determine the hazards
to human health.
Conclusions
In this study two lifelong cases of CGA are presented,
showing that dogs can be naturally infected concur-
rently with A. phagocytophilum variant 1, variant 4
and the HGE agent. The ongoing presence of specific
antibodies and Anaplasma DNA in one dog indicates
one year of persisting infection. Treatment with doxy-
cycline during recurring clinical episodes in the other
dog resulted in transient clinical improvement and
subsequent disappearance of specific antibodies and
DNA suggesting that re-infection occurred.
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Additional file
Additional file 1: Table S1. Tabulated quarter year life events and
serological, molecular, haematological and clinical data from six dogs,
1998 throughout 2009. Life histories of the six Rhodesian ridgeback dogs
described per quarter year from 1998 through 2009. For each dog 8
columns were annotated: a Life events and surgical interventions,
medications; b Rectal temperature taken in the veterinary clinic; c Clinical
observations especially bleeding tendencies and immunological derived
symptoms; d Other clinical observations as lameness, pain, fatigue,
tumors; e Thrombocyte counts; f Erythrocyte counts or form
observations; g White blood cell counts; h Serological and molecular
(DNA) detection of infection. Abbreviations: N, neutrophilia; n,
neutropenia; L, lymphocytosis; l, lymphopenia; M, monocytosis; m,
monocytopenia; E, eosinophilia; e, eosinopenia; Morula, morulae detected
in neutrophils; P/P both positive; P/N, serological positive/molecular
negative; N/P, serological negative/molecular positive; N/N, both
negative; -/N, -/P, N/-, P/-, -/-, either one or both not performed.
Note: No abbreviation is given for normal cell count. (XLS 176 kb)
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